MeiraGTx Holdings plc

MGTXNASDAQ · USD
11.75USD0.00 (-4.86%)
6510

MeiraGTx Holdings plc (MGTX) Straddle

MGTX straddle scan found 5 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 42.7%.

Read more

Trading a MGTX straddle lets you take a pure volatility position on MeiraGTx Holdings plc without committing to a direction. MeiraGTx Holdings plc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate MGTX straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on MGTX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when MeiraGTx Holdings plc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the MGTX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program.

The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the MGTX straddle is the cleanest expression of that view. Our scanner prices every MGTX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a MGTX straddle into a catalyst or short a MGTX straddle to harvest decay, the options straddle setups that matter are all in one place.

Apr 16, 202717.50$8.902067%42.7%$26.40$8.600
Apr 16, 202715.00$7.302067%40.3%$22.30$7.705
Apr 16, 202712.50$5.802067%40.1%$18.30$6.700
Jan 15, 202715.00$6.151157%37.0%$21.15$8.8534
Oct 16, 202620.00$10.08247%16.2%$30.08$9.930

As of September 23, 2026

Find the right straddle before volatility moves

Track MGTX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial